IP Library Granted Patent US 7,569,730
Granted Patent B2
US 7,569,730 · App. 12/054,917 · Granted Aug 4, 2009

Bisphosphine ligand

Assignee: Daiichi Fine Chemical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,730
App. No.
12/054,917
Granted
Aug 4, 2009
Kind
B2
Abstract

A compound represented by the following general formula (I): [wherein R 1 represents hydrogen atom, or an alkyl group, R 2 represents a hydroxyalkyl group, or a triarylmethyloxyalkyl group, or R 1 and R 2 combine together to represent —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, an alkyl group, or hydroxyl group, or R 3 and R 4 may combine together to represent oxo group), or —C(R 5 )(R 6 )—O—C(R 7 )(R 8 )— (R 5 to R 8 represent hydrogen atom, an alkyl group, or hydroxyl group, or R 5 and R 6 may combine together to represent oxo group, and R 7 and R 8 may combine together to represent oxo group); Ar 1 to Ar 4 independently represent an aryl group (the aryl group may have 1 to 5 of the same or different substituents), *1 to *4 indicate asymmetric carbons, and configurations are cis between *1 and *2, cis between *3 and *4, and trans between *2 and *3]. An optically active phosphine ligand which can be easily synthesized and gives a transition metal complex showing superior asymmetric catalyst activity is provided.

Claims (27)

1. A compound represented by the following general formula (I):

wherein

R 1 represents a hydrogen atom or an alkyl group,

R 2 represents a hydroxyalkyl group or a triarylmethyloxyalkyl group, or

R 1 and R 2 combine together to represent —C(R 3 )(R 4 )—, wherein

R 3 and R 4 independently represent a hydrogen atom, an alkyl group, or a hydroxyl group, or

R 3 and R 4 may combine together to represent an oxo group, or R 1 and R 2 combine together to represent —C(R 5 )(R 6 )—O—C(R 7 )(R 8 )—, wherein

R 5 , R 6 , R 7 and R 8 independently represent a hydrogen atom, an alkyl group, or a hydroxyl group, or

R 5 and R 6 may combine together to represent an oxo group, and/or

R 7 and R 8 may combine together to represent an oxo group; and

wherein

Ar 1 , Ar 2 , Ar 3 Ar 4 independently represent aryl group, which may have 1 to 5 of the same or different substituents, and wherein

*1, *2, *3 and *4 indicate asymmetric carbons, and relative steric configurations thereof are in cis-configuration between *1 and *2, cis-configuration between *3 and *4, and trans-configuration between *2 and *3.

2. The compound according to claim 1 , wherein Ar 1 , Ar 2 , Ar 3 and Ar 4 independently represent a phenyl group, which may have 1 to 5 of the same or different substituents.

3. The compound according to claim 1 , wherein Ar 1 , Ar 2 , Ar 3 and Ar 4 independently represent a phenyl group, or a 3,5-dialkyl-4-alkoxyphenyl group.

4. The compound according to claim 1 , wherein R 1 is a hydrogen atom, and R 2 is a hydroxyalkyl group.

5. The compound according to claim 1 , wherein R 1 is a hydrogen atom; or an alkyl group, and R 2 is a triphenylmethyloxyalkyl group.

6. The compound according to claim 1 , wherein R 1 and R 2 combine together to represent —C(R 3 )(R 4 )—, wherein R 3 and R 4 both represent a hydrogen atom, or R 3 and R 4 combine together to represent an oxo group.

7. The compound according to claim 1 , wherein R 1 and R 2 combine together to represent —C(R 5 )(R 6 )—O—C(R 7 )(R 8 )—, wherein R 5 and R 6 independently represent an alkyl group, and both R 7 and R 8 are hydrogen atoms.

8. The compound according to claim 1 and a transition metal, which together form a transition metal complex.

9. The transition metal complex according to claim 8 , wherein the transition metal is selected from rhodium, ruthenium, iridium, and palladium.

10. A catalyst for an asymmetric reaction, which comprises the transition metal complex according to claim 9 .

11. The catalyst according to claim 10 , which is used for an asymmetric hydrogenation reaction of an olefin, an imine, or a ketone, or an asymmetric 1,4-addition reaction of an enone.

12. A phosphine borane compound consisting of the compound according to claim 1 having boranes added on each of the two phosphorus atoms of the compound.

13. A method for preparing the compound according to claim 1 comprising:

having boranes added on each of the two phosphorus atoms of the compound and

treating a phosphine borane compound, consisting of the compound according to claim 1 having boranes added on each of the two phosphorus atoms of the compound, with a base.

Assignments (2)
CHANGE OF NAME Recorded Dec 24, 2015
From: DAIICHI FINE CHEMICAL CO., LTD.
To: KYOWA PHARMA CHEMICAL CO., LTD.
Reel/Frame 037372/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2008
From: WATANABE, MICHIMASA; TAKEUCHI, YUHKI; ISOBE, TAKAHIRO; TAKEUCHI, TADASHI
To: DAIICHI FINE CHEMICAL CO., LTD.
Reel/Frame 021065/0569 →
Priority Claims (1)
JP 2007-078384 · Mar 26, 2007 · national
Continuity (1)
Related Publication 20080242534A1 · Oct 2, 2008